Claudia Duarte joins EADA 2024 to share Foundation’s insights on tackling AMR

Aimed at fostering international cooperation and innovation in antimicrobials and diagnostics, EADA 2024 addresses the global challenge of antimicrobial resistance. This annual event gathers businesses, accelerators, funding agencies, and leading scientists to discuss the latest advancements in AMR research. 

On the second day of the event, Claudia will deliver a guest lecture titled “The Investors' Guide to Antimicrobial Resistance (AMR): A Growing Global Health Crisis.” In her lecture, she will present the Foundation's collaborative efforts with investors in the AMR sector, focusing on key initiatives such as the IAAMR Investor Statement, developed in partnership with the Investor Action on AMR Initiative, and the AMR Investor Guide. 

Later in the programme, Claudia will participate in the Round Table Discussion on Inclusive AMR Innovation. She will share valuable insights from the Foundation’s AMR Programme, including findings from earlier iterations of the AMR Benchmark report. Additionally, she will discuss the paper published in May on antimicrobial R&D, which emphasises the critical role of advanced stewardship and access planning in ensuring that innovative antibiotics and antifungals reach patients worldwide who are facing drug-resistant infections.